Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 12Multiple Myeloma 9Lymphoma 8Breast Neoplasms 8Lymphoma, Non-Hodgkin 7Hodgkin Disease 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Lymphoma, Large B-Cell, Diffuse 4Central Nervous System Neoplasms 4Burkitt Lymphoma 4Sarcoma 3Medulloblastoma 3Leukemia 3Brain Neoplasms 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Retinoblastoma 2Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Malignant mesenchymal tumor 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2

Interventions

Cisplatin 5Radiotherapy 4Carboplatin 4Peripheral Blood Stem Cell Transplantation 3Ifosfamide 3Etoposide 3liposomal amphotericin B 2Paclitaxel 2Filgrastim 2Cyclophosphamide 2Bleomycin 2lerisetron 1etoposide phosphate 1Vinblastine 1Ribavirin 1Palivizumab 1Ondansetron 1Magnetic Resonance Spectroscopy 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Granisetron 1Fluconazole 1Dexamethasone 1Caspofungin 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Seminoma × Granulocyte Colony-Stimulating Factor × Clear all
NCT02375204 2025-01-13

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
420 enrolled

Nonseminomatous germ cell tumor, Choriocarcinoma, Neoplasms, Germ Cell and Embryonal, Teratoma, Germinoma, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡